VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis In Vitro and In Vivo

Bladder cancer (BC) is one of the most common malignant tumors in the urinary system with growing morbidity and diagnostic rate in recent years. Therefore, identifying new molecular biomarkers that inhibit the progression of bladder cancer is needed for developing further therapeutics. This study fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jiacheng, Li, Tao, Ji, Hao, Chen, Zhi, Zhai, Baoqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086458/
https://www.ncbi.nlm.nih.gov/pubmed/35559251
http://dx.doi.org/10.3389/fphar.2022.874235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086458/
https://www.ncbi.nlm.nih.gov/pubmed/35559251
http://dx.doi.org/10.3389/fphar.2022.874235

Ejemplares similares